Transfusion and transplantation-related adverse events: Summary

Summary of national surveillance systems for transfusion errors, transfusion-transmitted injuries, and cells, tissues and organ transplantation.

  • Last updated: 2026-04-02

Beginning in 1998, the Government of Canada supported a number of voluntary national surveillance initiatives to strengthen blood safety and oversight in Canada. These included the:

The Public Health Agency of Canada’s Blood Safety Contribution Program (BSCP) administered these initiatives. They provided funding to provinces and territories to support the development and enhancement of systems that monitor adverse events, including:

The BSCP will end effective March 31, 2026.


You might also be interested in

Sexually transmitted and blood-borne infections: Indicator framework

Overview of 25 indicators of key sexually transmitted and blood-borne infections (STBBI) in Canada.

The Canadian Nosocomial Infection Surveillance Program (CNISP)

The CNISP summarizes trends in national incidence rates, antimicrobial resistance and molecular characterization for select healthcare-acquired infections and antimicrobial-resistant organisms.

All Health Infobase data products
Date modified: